Advertisement

Susac’s Syndrome

  • David Dao
  • Alan SheymanEmail author
Chapter
  • 41 Downloads
Part of the Retina Atlas book series (RA)

Abstract

Susac’s syndrome is microangiopathy defined by a triad of encephalopathy, sensorineural hearing loss, and multiple branch retinal artery occlusions. First case reports appeared in the literature in 1973 (Weidauer and Tenner 1973; Pfaffenbach and Hollenhorst 1973) and in 1979, Dr. John O. Susac published reports of microangiopathy of the brain and retina in two young women (Susac et al. 1979). Since first reported in the 1970s, approximately 300 case reports have been published on the disease. Susac’s syndrome most commonly affects young women and was initially only thought to affect females, however, it has been reported in males also. A recent systematic case review of all reported cases found a 3.5 to 1 female to male predominance and an average age of onset between 21 and 35 years (Dörr et al. 2013).

Notes

Acknowledgments and Attributions

Figures 12.2, 12.3, and 12.4 contributed by Sumit Sharma, MD at Cole Eye Institute at the Cleveland Clinic.

Figures 12.1 and 12.5 contributed by Ramesh R Shah MD, FACS, FICS

References

  1. Aubart-Cohen F, et al. Long-term outcome in Susac syndrome. Medicine. 2007;86:93–102.CrossRefGoogle Scholar
  2. Bernard JT, Romero R, Agrawal K, Jager R, Rezania K. Optical coherence tomography in Susac’s syndrome. Mult Scler Relat Disord. 2014;3:110–6.CrossRefGoogle Scholar
  3. Boukouvala S, Jacob S, Lane M, Denniston AK, Burdon MA. Detection of branch retinal artery occlusions in Susac’s syndrome. BMC Res Notes. 2014;7:56.CrossRefGoogle Scholar
  4. Brandt AU, et al. Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS. PLoS One. 2012;7:e38741.CrossRefGoogle Scholar
  5. Demir M, Case K. 142: Susac syndrome. Radiology. 2009;250:598–602.CrossRefGoogle Scholar
  6. Dörr J, et al. Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome. Nat Rev Neurol. 2009;5:683–8.CrossRefGoogle Scholar
  7. Dörr J, et al. Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol. 2013;9:307–16.CrossRefGoogle Scholar
  8. Egan RA, et al. Retinal arterial wall plaques in Susac syndrome. Am J Ophthalmol. 2003;135:483–6.CrossRefGoogle Scholar
  9. Egan RA, Hills WL, Susac JO. Gass plaques and fluorescein leakage in Susac syndrome. J Neurol Sci. 2010;299:97–100.CrossRefGoogle Scholar
  10. Förl B, Krastel H, Hartmann M, Kolling G. Susac syndrome: follow-up of visual fields and multifocal electroretinogram after treatment with intravenous immunoglobulins. Neuroophthalmology. 2007;31:3–6.CrossRefGoogle Scholar
  11. Gass JD, Tiedeman J, Thomas MA. Idiopathic recurrent branch retinal arterial occlusion. Ophthalmology. 1986;93:1148–57.CrossRefGoogle Scholar
  12. Gharbiya M, et al. Indocyanine green angiographic findings for patients with systemic lupus erythematosus nephropathy. Retina. 2006;26:159–64.CrossRefGoogle Scholar
  13. Jarius S, Neumayer B, Wandinger KP, Hartmann M, Wildemann B. Anti-endothelial serum antibodies in a patient with Susac’s syndrome. J Neurol Sci. 2009;285:259–61.CrossRefGoogle Scholar
  14. London F, Pothalil D, Duprez TP, Sindic CJM. Potential benefits of early aggressive immunotherapy in Susac syndrome. Acta Neurol Belg. 2016;116:451–60.CrossRefGoogle Scholar
  15. Magro CM. Susac’s syndrome: an autoimmune endotheliopathy. In: 1st Susac symposium held at Ohio State University, Columbus; 2005.Google Scholar
  16. Magro CM, Poe JC, Lubow M, Susac JO. Susac syndrome: an organ-specific autoimmune endotheliopathy syndrome associated with anti-endothelial cell antibodies. Am J Clin Pathol. 2011;136:903–12.CrossRefGoogle Scholar
  17. Mallam B, Damato EM, Scolding NJ, Bailey C. Serial retinal fluorescein angiography and immune therapy in Susac’s syndrome. J Neurol Sci. 2009;285:230–4.CrossRefGoogle Scholar
  18. Martinet N, et al. Fluorescein and indocyanine green angiographies in Susac syndrome. Retina. 2007;27:1238–42.CrossRefGoogle Scholar
  19. Matsuo T, Sato Y, Shiraga F, Shiragami C, Tsuchida Y. Choroidal abnormalities in Behçet disease observed by simultaneous indocyanine green and fluorescein angiography with scanning laser ophthalmoscopy. Ophthalmology. 1999;106:295–300.CrossRefGoogle Scholar
  20. Negi VS, Tripathy NK, Misra R, Nityanand S. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol. 1998;25:462–6.PubMedGoogle Scholar
  21. Petty GW, et al. Retinocochleocerebral vasculopathy. Medicine. 1998;77:12–40.CrossRefGoogle Scholar
  22. Petty GW, Matteson EL, Younge BR, McDonald TJ, Wood CP. Recurrence of Susac syndrome (retinocochleocerebral vasculopathy) after remission of 18 years. Mayo Clin Proc. 2001;76:958–60.CrossRefGoogle Scholar
  23. Pfaffenbach DD, Hollenhorst RW. Microangiopathy of the retinal arterioles. JAMA. 1973;225:480–3.CrossRefGoogle Scholar
  24. Pope-Harman A, Ross P, Magro C, Kelsey M. C4D as a diagnostic adjunct in lung allograft biopsies. J Heart Lung Transplant. 2003;22:S103.CrossRefGoogle Scholar
  25. Rennebohm RM, Egan RA, Susac JO. Treatment of Susac’s syndrome. Curr Treat Options Neurol. 2008a;10:67–74.CrossRefGoogle Scholar
  26. Rennebohm RM, et al. Aggressive immunosuppressive treatment of Susac’s syndrome in an adolescent: using treatment of dermatomyositis as a model. Pediatr Rheumatol Online J. 2008b;6:3.CrossRefGoogle Scholar
  27. Rennebohm R, Susac JO, Egan RA, Daroff RB. Susac’s syndrome—update. J Neurol Sci. 2010;299:86–91.CrossRefGoogle Scholar
  28. Saw VP, et al. Susac syndrome: microangiopathy of the retina, cochlea and brain. Clin Exp Ophthalmol. 2000;28:373–81.CrossRefGoogle Scholar
  29. Spiess K, Martínez JRG. OCT angiography: assessment of retinal ischemia in Susac’s syndrome. Ophthalmic Surg Lasers Imaging Retina. 2017;48:505–8.CrossRefGoogle Scholar
  30. Susac JO, Hardman JM, Selhorst JB. Microangiopathy of the brain and retina. Neurology. 1979;29:313–6.CrossRefGoogle Scholar
  31. Susac JO, et al. MRI findings in Susac’s syndrome. Neurology. 2003;61:1783–7.CrossRefGoogle Scholar
  32. Susac JO, Egan RA, Rennebohm RM, Lubow M. Susac’s syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy. J Neurol Sci. 2007;257:270–2.CrossRefGoogle Scholar
  33. Tashima K, Uyama E, Hashimoto Y, Yonehara T, Uchino M. Susac’s syndrome: beneficial effects of corticosteroid therapy in a Japanese case. Intern Med. 2001;40:135–9.CrossRefGoogle Scholar
  34. Vodopivec I, Prasad S. Treatment of Susac syndrome. Curr Treat Options Neurol. 2016;18:3.CrossRefGoogle Scholar
  35. Vodopivec I, Venna N, Rizzo JF 3rd, Prasad S. Clinical features, diagnostic findings, and treatment of Susac syndrome: a case series. J Neurol Sci. 2015;357:50–7.CrossRefGoogle Scholar
  36. Weidauer H, Tenner A. Bilateral acute hearing loss with transient occlusion of a branch of the retinal artery on both sides. Z Laryngol Rhinol Otol. 1973;52:121–8.PubMedGoogle Scholar
  37. Xu MS, Tan CB, Umapathi T, Lim CCT. Susac syndrome: serial diffusion-weighted MR imaging. Magn Reson Imaging. 2004;22:1295–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.Department of OphthalmologyUniversity of MarylandBaltimoreUSA

Personalised recommendations